SlideShare a Scribd company logo
1 of 15
ERIC J. LULLOVE, DPM, CWS, FACCWS
                   BOCA RATON, FL
Exsalt™ SD7 Wound Dressing

Description
The exsaltTM SD7 wound dressing provides an antimicrobial barrier that
inhibits microbial growth in the dressing. The exsalt™ SD7 wound dressing
consists of three layers: two non-adherent polyethylene mesh wound contact
layers and one absorbent core made of polyester. All three layers are silver
coated. The concentration of silver on the exsalt™ SD7 wound dressing is
approximately 0.4 mg/cm2 (2.5% w/w).


Indications
The exsaltTM SD7 wound dressing is indicated for the management of partial
and full thickness wounds, including decubitus ulcers, venous stasis
ulcers, diabetic ulcers, first and second degree burns, grafts and donor sites, or
other acute or chronic wounds. The dressing may be used over debrided and
grafted wounds.
   74 year old female presents with chronic
    non-healing ulcer of her right leg. Area was
    clotted and necrotic pre-debridement.
   Post-debridement patient developed local
    contamination of the ulcer site, and Exalt SD7
    was used to reduce bacterial load.
   Exalt was used to complete wound closure.
Complete Healing at 7 weeks
   52 year old diabetic male admitted to local
    hospital for gas gangrene of the left foot.
   Patient underwent partial 1st ray resection and
    delayed primary closure.
   Exalt SD7 used post-operatively in
    management of heavy exudate with
    significant malodor.
   Clinically, patient improved after 1 week and
    remarkable healing after 1 month.
Note the amount
Of silver absorbed by the
wound bed with the dressing
able to withstand one week
application without dressing
change
Patient is slowly progressing to
healing, but has not needed
additional Exalt DS-7 since 10-8-10.
   83 year old male with history of severe left
    lower extremity edema presented with
    chronic venous ulcers to left medial ankle.
   Exalt DS-7 used to absorb exudate and
    provide a stable clean wound bed to the area
    to promote more granulation tissue and less
    aggressive bacterial dermatitis.
Exalt DS-7 started 4-5-10 after positive
culture for MRSA to wound bed
Two weeks of Exalt DS-7 with        Complete Healing Noted
eradication of MRSA infection and
healing.
   Exalt SD7 has shown in the preceding cases
    that it is a viable dressing alternative to other
    silver products as its nature of a 3+ valency
    allows for more aqueous silver to penetrate
    the wound bed. This technology allows for
    more rapid-onset reduction of bacterial load
    and therefore, increased healing rates.

More Related Content

Similar to Exalt Sd7 Clinical Case Studies

Surgical wound care
Surgical wound careSurgical wound care
Surgical wound careSamboGlo
 
surgicalwoundcare-211022084bhlotfo042.pdf
surgicalwoundcare-211022084bhlotfo042.pdfsurgicalwoundcare-211022084bhlotfo042.pdf
surgicalwoundcare-211022084bhlotfo042.pdfHappychifunda
 
Current management of acute cutaneous wounds nejm
Current management of acute cutaneous wounds nejmCurrent management of acute cutaneous wounds nejm
Current management of acute cutaneous wounds nejmshimaken
 
Exalt Sd7 Sawc Spring 2012 Poster
Exalt Sd7 Sawc Spring 2012 PosterExalt Sd7 Sawc Spring 2012 Poster
Exalt Sd7 Sawc Spring 2012 Posterdrlullove
 
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...EWMAConference
 
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...EWMA
 
Masquelet technique for management of large bone defects.
Masquelet technique for management of large bone defects.Masquelet technique for management of large bone defects.
Masquelet technique for management of large bone defects.Kushi Rithvic
 
Masquelet technique for management of large bone defects.
Masquelet technique for management of large bone defects.Masquelet technique for management of large bone defects.
Masquelet technique for management of large bone defects.Kushi Rithvic
 
2012 stiller-ohr-rekonstruktion-1
2012 stiller-ohr-rekonstruktion-12012 stiller-ohr-rekonstruktion-1
2012 stiller-ohr-rekonstruktion-1Klinikum Lippe GmbH
 

Similar to Exalt Sd7 Clinical Case Studies (15)

Surgical wound care
Surgical wound careSurgical wound care
Surgical wound care
 
surgicalwoundcare-211022084bhlotfo042.pdf
surgicalwoundcare-211022084bhlotfo042.pdfsurgicalwoundcare-211022084bhlotfo042.pdf
surgicalwoundcare-211022084bhlotfo042.pdf
 
Current management of acute cutaneous wounds nejm
Current management of acute cutaneous wounds nejmCurrent management of acute cutaneous wounds nejm
Current management of acute cutaneous wounds nejm
 
Casestudies6nov2013
Casestudies6nov2013Casestudies6nov2013
Casestudies6nov2013
 
avulsion
avulsionavulsion
avulsion
 
Exalt Sd7 Sawc Spring 2012 Poster
Exalt Sd7 Sawc Spring 2012 PosterExalt Sd7 Sawc Spring 2012 Poster
Exalt Sd7 Sawc Spring 2012 Poster
 
IV 3000: An Innovative Fingertip Dressing
IV 3000: An Innovative Fingertip DressingIV 3000: An Innovative Fingertip Dressing
IV 3000: An Innovative Fingertip Dressing
 
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
 
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
EWMA 2013 - Ep472 -USE OF A NEW HYDRO-DESLOUGHING DRESSING* IN EXUDING AND SL...
 
Openfracture
OpenfractureOpenfracture
Openfracture
 
Masquelet technique for management of large bone defects.
Masquelet technique for management of large bone defects.Masquelet technique for management of large bone defects.
Masquelet technique for management of large bone defects.
 
Masquelet technique for management of large bone defects.
Masquelet technique for management of large bone defects.Masquelet technique for management of large bone defects.
Masquelet technique for management of large bone defects.
 
2012 stiller-ohr-rekonstruktion-1
2012 stiller-ohr-rekonstruktion-12012 stiller-ohr-rekonstruktion-1
2012 stiller-ohr-rekonstruktion-1
 
Vac therapy
Vac therapyVac therapy
Vac therapy
 
Artificial skin
Artificial skinArtificial skin
Artificial skin
 

Exalt Sd7 Clinical Case Studies

  • 1. ERIC J. LULLOVE, DPM, CWS, FACCWS BOCA RATON, FL
  • 2. Exsalt™ SD7 Wound Dressing Description The exsaltTM SD7 wound dressing provides an antimicrobial barrier that inhibits microbial growth in the dressing. The exsalt™ SD7 wound dressing consists of three layers: two non-adherent polyethylene mesh wound contact layers and one absorbent core made of polyester. All three layers are silver coated. The concentration of silver on the exsalt™ SD7 wound dressing is approximately 0.4 mg/cm2 (2.5% w/w). Indications The exsaltTM SD7 wound dressing is indicated for the management of partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and grafted wounds.
  • 3. 74 year old female presents with chronic non-healing ulcer of her right leg. Area was clotted and necrotic pre-debridement.  Post-debridement patient developed local contamination of the ulcer site, and Exalt SD7 was used to reduce bacterial load.  Exalt was used to complete wound closure.
  • 4.
  • 5.
  • 7. 52 year old diabetic male admitted to local hospital for gas gangrene of the left foot.  Patient underwent partial 1st ray resection and delayed primary closure.  Exalt SD7 used post-operatively in management of heavy exudate with significant malodor.  Clinically, patient improved after 1 week and remarkable healing after 1 month.
  • 8.
  • 9. Note the amount Of silver absorbed by the wound bed with the dressing able to withstand one week application without dressing change
  • 10.
  • 11. Patient is slowly progressing to healing, but has not needed additional Exalt DS-7 since 10-8-10.
  • 12. 83 year old male with history of severe left lower extremity edema presented with chronic venous ulcers to left medial ankle.  Exalt DS-7 used to absorb exudate and provide a stable clean wound bed to the area to promote more granulation tissue and less aggressive bacterial dermatitis.
  • 13. Exalt DS-7 started 4-5-10 after positive culture for MRSA to wound bed
  • 14. Two weeks of Exalt DS-7 with Complete Healing Noted eradication of MRSA infection and healing.
  • 15. Exalt SD7 has shown in the preceding cases that it is a viable dressing alternative to other silver products as its nature of a 3+ valency allows for more aqueous silver to penetrate the wound bed. This technology allows for more rapid-onset reduction of bacterial load and therefore, increased healing rates.